Prostate-specific membrane antigen radioligand therapy of prostate cancer

被引：6
|
作者：
Beheshti, Mohsen [1 ,2 ]
Heinzel, Alexander [1 ]
von Mallek, Dirk [1 ]
Filss, Christian [1 ]
Mottaghy, Felix M. [1 ,3 ]
机构：
[1] RWTH Univ, Univ Hosp, Dept Nucl Med, Pauwelsstr 30, D-52074 Aachen, Germany
[2] Paracelsus Med Univ, Dept Nucl Med & Endocrinol, Salzburg, Austria
[3] Maastricht Univ, Dept Radiol & Nucl Med, Med Ctr, Maastricht, Netherlands
来源：
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 63卷 / 01期
关键词：
Prostatic neoplasms; Lu-177-PSMA-617; Radiotherapy; TARGETED ALPHA-THERAPY; RADIATION-DOSIMETRY; PSMA LIGANDS; PRECLINICAL EVALUATION; RADIONUCLIDE THERAPY; PHASE-II; BIODISTRIBUTION; INHIBITORS; PET; ANTIBODY;
D O I：
10.23736/S1824-4785.19.03155-8
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Defining an optimal therapeutic approach in metastatic castration-resistance prostate cancer (mCRPC) patients in advanced stages is still chal-lengina in routine clinical practice. Prostate-specific membrane antigen (PSMA) targeted radionuclide therapy with beta- or alpha-emitters such as 177-Lutethium (Lu-177) or 225-Actinium ((225)A) has been a main focus at multiple academic research centers in the last few years. This review article provides an overview of PSMA characteristics. clinical performance, safety and toxicity of PSMA targeted beta- or alpha-radiation therapy.
引用
收藏
页码：29 / 36
页数：8
相关论文
共 50 条
  • [1] Current Status of Prostate-specific Membrane Antigen-targeted Alpha Radioligand Therapy in Prostate Cancer
    Yamamichi, Gaku
    Kato, Taigo
    Watabe, Tadashi
    Hatano, Koji
    Uemura, Motohide
    Nonomura, Norio
    [J]. ANTICANCER RESEARCH, 2024, 44 (03) : 879 - 888
  • [2] Targeting the prostate-specific membrane antigen for prostate cancer therapy
    Buehler, Patrick
    Wolf, Philipp
    Elsaesser-Beile, Ursula
    [J]. IMMUNOTHERAPY, 2009, 1 (03) : 471 - 481
  • [3] Prostate-specific membrane antigen radioligand therapy with alpha emitters, a review
    Privé B.M.
    van Gemert W.A.M.
    Nagarajah J.
    Mehra N.
    Gerritsen W.R.
    van Oort I.M.
    Gotthardt M.
    Heskamp S.
    Janssen M.J.R.
    [J]. Tijdschrift voor Urologie, 2020, 10 (6-7) : 147 - 154
  • [4] Prostate-specific membrane antigen (PSMA)-ligand positron emission tomography and radioligand therapy (RLT) of prostate cancer
    Tateishi, Ukihide
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (04) : 349 - 356
  • [5] Mechanisms of Resistance to Prostate-Specific Membrane Antigen-Targeted Radioligand Therapy in a Mouse Model of Prostate Cancer
    Stuparu, Andreea D.
    Capri, Joseph R.
    Meyer, Catherine A. L.
    Le, Thuc M.
    Evans-Axelsson, Susan L.
    Current, Kyle
    Lennox, Mark
    Mona, Christine E.
    Fendler, Wolfgang P.
    Calais, Jeremie
    Eiber, Matthias
    Dahlbom, Magnus
    Czernin, Johannes
    Radu, Caius G.
    Lueckerath, Katharina
    Slavik, Roger
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (07): : 989 - 995
  • [6] Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy
    Hartrampf, Philipp E.
    Weinzierl, Franz-Xaver
    Seitz, Anna Katharina
    Kuebler, Hubert
    Essler, Markus
    Buck, Andreas K.
    Werner, Rudolf A.
    Bundschuh, Ralph A.
    [J]. PROSTATE, 2022, 82 (14): : 1406 - 1412
  • [7] Narrative review: prostate-specific membrane antigen-radioligand therapy in metastatic castration-resistant prostate cancer
    Lunger, Lukas
    Tauber, Robert
    Feuerecker, Benedikt
    Gschwend, Jurgen E.
    Eiber, Matthias
    Heck, Matthias M.
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (10) : 3963 - 3971
  • [8] Prostate-specific Membrane Antigen PET in Prostate Cancer
    Lawhn-Heath, Courtney
    Salavati, Ali
    Behr, Spencer C.
    Rowe, Steven P.
    Calais, Jeremie
    Fendler, Wolfgang P.
    Eiber, Mattias
    Emmett, Louise
    Hofman, Michael S.
    Hope, Thomas A.
    [J]. RADIOLOGY, 2021, 299 (02) : 248 - 260
  • [9] Targeting epitopes in prostate-specific membrane antigen for antibody therapy of prostate cancer
    Y Kinoshita
    K Kuratsukuri
    N Newman
    P M Rovito
    P T P Kaumaya
    C Y Wang
    G P Haas
    [J]. Prostate Cancer and Prostatic Diseases, 2005, 8 : 359 - 363
  • [10] Emerging Theranostics for Prostate Cancer and a Model of Prostate-specific Membrane Antigen Therapy
    Jewell, Kerry
    Hofman, Michael S.
    Ong, Jeremy S. L.
    Levy, Sidney
    [J]. RADIOLOGY, 2024, 311 (01)
12345